← Eichor
Study identifier: NCT06323876 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis

Condition: Idiopathic Pulmonary Fibrosis  ·  Sponsor: University of Virginia

PhaseN/A
Planned participants160
Who can joinAll sexes, 40 Years to 101 Years
Healthy volunteersNo

About this study

This observational study involves obtaining 2 chest CT scans; a historical baseline CT within ±1 year of enrollment into PRECISIONS, and a follow-up CT (either historical or prospective) 12 months ± 180 days after the baseline CT. Many IPF patients will have a CT scan every 12 months for disease monitoring and cancer screening. Participants will have the option to share historical CTs only or they can choose to have a research CT done for the follow-up scan, if a scan for clinical purposes is not available.

This description comes directly from the study's public registry record.

Talk to the study team

Roselove Nunoo-Asare  ·  4342436074  ·  rnn3b@uvahealth.org

Diana Hsu, MA  ·  NBR2DF@uvahealth.org

Always discuss trial participation with your own doctor first.

Locations (1)

University of VirginiaCharlottesville, Virginia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06323876